MEK MUTATION
Clinical trials for MEK MUTATION explained in plain language.
Never miss a new study
Get alerted when new MEK MUTATION trials appear
Sign up with your email to follow new studies for MEK MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Cancer's 'MAPK Pathway' in patients out of options
Disease control Recruiting nowThis is a first-in-human study testing a new oral drug called NST-628 in adults with advanced solid tumors that have specific genetic changes. The main goals are to find a safe dose and see how the body processes the drug. The trial is for patients whose cancer has continued to g…
Matched conditions: MEK MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
Last-Hope cancer drug offered to desperate patients
Disease control AVAILABLEThis program provides access to an investigational drug called ulixertinib for patients with advanced cancers that have specific genetic changes (MAPK pathway mutations). It is for people who have run out of other treatment options. The drug aims to control the cancer's growth, e…
Matched conditions: MEK MUTATION
Sponsor: xCures • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC